Fibrocell Science (FCSC) Misses Q2 EPS by 3c
Fibrocell Science (NASDAQ: FCSC) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $87 thousand versus the consensus estimate of $70 thousand.
For earnings history and earnings-related data on Fibrocell Science (FCSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Freedom Broker Upgrades Garrett Motion (GTX) to Buy
- Citi raises General Dynamics price target to $400, keeps Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share